Literature DB >> 7831778

Generation of humoral immune responses against herpes simplex virus type 2 in the murine female genital tract.

G N Milligan1, D I Bernstein.   

Abstract

A murine model of genital infection with a thymidine kinase-deficient (tk-) strain of herpes simplex virus type 2 (HSV-2) was utilized to examine the local urogenital antibody response to HSV-2. Vaginal inoculation with HSV-2 tk- protected against a subsequent genital challenge with a lethal dose of virulent HSV-2. After primary vaginal infection, predominantly HSV-specific IgG antibodies were detected in serum and vaginal secretions. HSV-specific IgG antibody-secreting cells (ASC) were detected first and in greatest numbers in the genital lymph nodes (gLN) after primary HSV-2 tk- inoculation. HSV-specific IgG or IgA ASC were not detected in the urogenital mucosa after primary HSV-2 vaginal infection. Vaginal HSV-2 challenge of HSV-immune mice resulted in increased HSV-specific serum IgG antibody and vaginal IgA antibody titers. HSV-specific IgG ASC were detected by 4 days postchallenge in gLN and by Days 6 and 7 postchallenge in the spleen and genital mucosa. These results suggest that urogenital humoral responses originate in the gLN following HSV genital infection and that gLN may serve as the primary source of the HSV-specific IgG- and IgA-secreting cells present in the urogenital mucosa after vaginal challenge.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7831778     DOI: 10.1016/s0042-6822(95)80038-7

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  36 in total

1.  B7 costimulation plays an important role in protection from herpes simplex virus type 2-mediated pathology.

Authors:  Lydia G Thebeau; Lynda A Morrison
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

2.  Immunization with combined HSV-2 glycoproteins B2 : D2 gene DNAs: protection against lethal intravaginal challenges in mice.

Authors:  Hyung Hoan Lee; Soung Chul Cha; Dong June Jang; Jun Keun Lee; Dong Wan Choo; Young Sik Kim; Hong Sun Uh; Soo Young Kim
Journal:  Virus Genes       Date:  2002-10       Impact factor: 2.332

3.  Teleost skin, an ancient mucosal surface that elicits gut-like immune responses.

Authors:  Zhen Xu; David Parra; Daniela Gómez; Irene Salinas; Yong-An Zhang; Louise von Gersdorff Jørgensen; Rasmus Demuth Heinecke; Kurt Buchmann; Scott LaPatra; J Oriol Sunyer
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-24       Impact factor: 11.205

4.  Immunoglobulin G is the main protective antibody in mouse vaginal secretions after vaginal immunization with attenuated herpes simplex virus type 2.

Authors:  E L Parr; M B Parr
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

5.  Quantitative analysis of herpes simplex virus type 1-specific memory B cells generated by different routes of infection.

Authors:  Daisy J Vanitha; Hye Mee Joo; Barry T Rouse; Mark Y Sangster
Journal:  Virology       Date:  2006-11-17       Impact factor: 3.616

6.  Development of an anti-guinea pig CD4 monoclonal antibody for depletion of CD4+ T cells in vivo.

Authors:  Brianne N Banasik; Clarice L Perry; Celeste A Keith; Nigel Bourne; Hubert Schäfer; Gregg N Milligan
Journal:  J Immunol Methods       Date:  2019-08-14       Impact factor: 2.303

7.  Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus.

Authors:  T Muster; B Ferko; A Klima; M Purtscher; A Trkola; P Schulz; A Grassauer; O G Engelhardt; A García-Sástre; P Palese
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

8.  Long-term presence of virus-specific plasma cells in sensory ganglia and spinal cord following intravaginal inoculation of herpes simplex virus type 2.

Authors:  Gregg N Milligan; Michael G Meador; Chin-Fun Chu; Christal G Young; Talitha L Martin; Nigel Bourne
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  Immunity to vaginal HSV-2 infection in immunoglobulin A knockout mice.

Authors:  M B Parr; G R Harriman; E L Parr
Journal:  Immunology       Date:  1998-10       Impact factor: 7.397

10.  FSL-1, a bacterial-derived toll-like receptor 2/6 agonist, enhances resistance to experimental HSV-2 infection.

Authors:  William A Rose; Chris L McGowin; Richard B Pyles
Journal:  Virol J       Date:  2009-11-10       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.